Glucose-Lowering Effects of Imeglimin and Its Possible Beneficial Effects on Diabetic Complications.

Biology (Basel) · 2023 · PMC10215333 · PMID 37237539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The 90 day-imeglimin treatment significantly reduced interstitial fibrosis; while the glomerular injury score and interstitial inflammation were also reduced, the reduction did not reach statistical significance. 5.4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.